United States · Series A startup

Who invested in Apeiron labs

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$9.5Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $9.5MFeb 2026
Investors
3
See who backed them

The rounds

  1. Feb 2026

Founders and team

From Apeiron labs's own website: 2 on the team.

  • Ravi PappuCEO / Board Member
  • Will O’HalloranVP, Engineering

Everyone who backed them

MassChallengeAccelerator1round
RA Capital ManagementPrivate equity1round
S2G InvestmentsGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Apeiron labs as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Coalition VenturesVenture studioPer its own site

Quick answers about Apeiron labs

Who invested in Apeiron labs?

Apeiron labs's investors include MassChallenge, RA Capital Management and S2G Investments.

How much has Apeiron labs raised?

Apeiron labs has raised $9.5M across 1 round since 2026.

When did Apeiron labs last raise?

Apeiron labs's most recent round was a Series A of $9.5M in Feb 2026.

What was Apeiron labs's biggest round?

Its most recent round, $9.5M in Feb 2026, is also its largest on record.

Who backed Apeiron labs first?

Apeiron labs's first round on record, in Feb 2026, was backed by MassChallenge, RA Capital Management and S2G Investments.

What stage is Apeiron labs at?

Apeiron labs's latest named round is a Series A, in Feb 2026.

Where is Apeiron labs based?

Apeiron labs is based in the United States.

Companies like Apeiron labs

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.